755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars

Inclusion criteria

• Healthy male or female subjects between 18 and 85 years of age.
• Subjects with Fitzpatrick skin types I to VI.
• Subjects who have unwanted pigmented lesions, vascular lesions, striae and/or hypertrophic or atrophic scars
• Subject who are willing to consent to participate in the study.

4.2 Exclusion Criteria

• Subject who will not be photographed or who will not cooperate with the post treatment care and follow up schedule
• Hypersensitive to light exposure.
• Active localized or systemic infections.
• Taking medication for which sunlight is a contraindication.
• History of squamous cell carcinoma or melanoma.
• History of keloid scarring.
• Use of oral isotretinoin (Accutane®) within 12 months of initial treatment or during the course of the study. Note: Skin must regain its normal degree of moisture prior to treatment.
• Prior treatment with laser or other devices in treatment area within 3 months
• History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications.
• Subjects who are pregnant, have been pregnant within the last 3 months, are currently breast feeding or are planning a pregnancy within the study period.
• Subjects that the physician determines ineligible based on standard of care treatment.

-

-